Advertisement
Persistent Systems Limited (NSE:PERSISTENT), might not be a large cap stock, but it led the NSEI gainers with a relatively large price hike in the past couple of weeks. As a stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. But what if there is still an opportunity to buy? Let’s examine Persistent Systems’s valuation and outlook in more detail to determine if there’s still a bargain opportunity.
Check out our latest analysis for Persistent Systems
What is Persistent Systems worth?
According to my price multiple model, where I compare the company's price-to-earnings ratio to the industry average, the stock currently looks expensive. I’ve used the price-to-earnings ratio in this instance because there’s not enough visibility to forecast its cash flows. The stock’s ratio of 25.36x is currently well-above the industry average of 16.78x, meaning that it is trading at a more expensive price relative to its peers. In addition to this, it seems like Persistent Systems’s share price is quite stable, which could mean two things: firstly, it may take the share price a while to fall back down to an attractive buying range, and secondly, there may be less chances to buy low in the future once it reaches that value. This is because the stock is less volatile than the wider market given its low beta.
What kind of growth will Persistent Systems generate?
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. With profit expected to grow by 34% over the next couple of years, the future seems bright for Persistent Systems. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.
What this means for you:
Are you a shareholder? PERSISTENT’s optimistic future growth appears to have been factored into the current share price, with shares trading above industry price multiples. However, this brings up another question – is now the right time to sell? If you believe PERSISTENT should trade below its current price, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.
Are you a potential investor? If you’ve been keeping an eye on PERSISTENT for a while, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the positive outlook is encouraging for PERSISTENT, which means it’s worth diving deeper into other factors in order to take advantage of the next price drop.
With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. While conducting our analysis, we found that Persistent Systems has 3 warning signs and it would be unwise to ignore these.
If you are no longer interested in Persistent Systems, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
If you’re looking to trade Persistent Systems, open an account with the lowest-cost* platform trusted by professionals, Interactive Brokers. Their clients from over 200 countries and territories trade stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.
About NSEI:PERSISTENT
Persistent Systems
Provides software products, services, and technology solutions in India, North America, and internationally.
Outstanding track record with flawless balance sheet and pays a dividend.
Similar Companies
Market Insights
Advertisement
Weekly Picks
LO
Lou_Basenese on Optimi Health ·
The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist
Fair Value:US$1155.3% undervalued
51 followersusers have followed this narrative
2 commentsusers have commented on this narrative
9 likesusers have liked this narrative
BL
BlackGoat on IREN ·
IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers
Fair Value:US$71.4849.2% undervalued
205 followersusers have followed this narrative
6 commentsusers have commented on this narrative
32 likesusers have liked this narrative
HE
HedgeY on Arm Holdings ·
The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?
Fair Value:US$43038.1% undervalued
9 followersusers have followed this narrative
1 commentusers have commented on this narrative
3 likesusers have liked this narrative
HI
Hidden_Rock_Capital on Fiserv ·
Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings
Fair Value:US$119.9956.4% undervalued
13 followersusers have followed this narrative
0 commentsusers have commented on this narrative
6 likesusers have liked this narrative
Recently Updated Narratives
ON
Ontological on Lotus Technology ·
Lotus Tech, Finloop and FOMO Pay Collaborate to Explore Vehicle Tokenization
Fair Value:US$2.463.9% undervalued
1 followerusers have followed this narrative
1 commentusers have commented on this narrative
0 likesusers have liked this narrative
NE
newsfinder11221 on Robo.ai ·
Robo.ai (NASDAQ: AIIO): Building the Infrastructure Behind the AI Revolution
Fair Value:US$540.4% undervalued
1 followerusers have followed this narrative
3 commentsusers have commented on this narrative
0 likesusers have liked this narrative
EU
European_Hidden_Gem_Stocks on MINT Société anonyme ·
Mint SA: A French Micro-Cap Energy Retailer Worth Watching
Fair Value:€1153.1% undervalued
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Popular Narratives
CU
CubanEros on Microsoft ·
A wonderful business at reasonable price.
Fair Value:US$419.917.3% undervalued
88 followersusers have followed this narrative
0 commentsusers have commented on this narrative
6 likesusers have liked this narrative
OS
oscargarcia on NVIDIA ·
The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.
Fair Value:US$28029.8% undervalued
199 followersusers have followed this narrative
9 commentsusers have commented on this narrative
15 likesusers have liked this narrative
BE
benjamin_lvieq on PayPal Holdings ·
PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback
Fair Value:US$6513.7% undervalued
73 followersusers have followed this narrative
2 commentsusers have commented on this narrative
11 likesusers have liked this narrative
Trending Discussion
DE
derek_3wsdg on Teladoc Health ·
You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.
1
|0
